Sulfadiazine Sodium Injection Market Outlook and Opportunity Analysis with Major Key Players

Sulfadiazine Sodium Injection Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Sulfadiazine Sodium Injection Market – Overview
Rising awareness for safe antibiotic uses due to widespread antibiotic resistance can drive high demand for
sulfadiazine sodium injection in the global market during the forecast period. For instance, World
Antibiotic Awareness Week (WAAW) observed every year in the month of November, purposes to increase
global awareness of antibiotic resistance (AMR) and encourage best practices among public, health
workers, and policy makers to avoid emergence and spread of antibiotic resistance.
Furthermore, the mission of Alliance for the Prudent Use of Antibiotics (APUA) started in 1981, is
working to strengthen global defenses against infectious diseases by ensuring access to effective antibiotics
treatment and promoting appropriate antibiotic use to reduce drug resistance. By 2018, APUA is working
in 19 countries and stands as the world’s leading organization conducting research and education on
antimicrobial treatment and resistance at the grassroots and global levels.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Sulfadiazine Sodium Injection Market :
North America is estimated to hold the leading position in sulfadiazine sodium injection market due to
rising use of antibiotics. For instance, according to the U.S. Food and Drug Administration (USFDA) 2015,
about 9.7 million kilograms (21.4 million pounds) of antibiotics considered important for human use were
sold for use in animal agriculture.
Europe is also expected to witness significant growth in the global sulfadiazine sodium injection market,
owing to rising awareness of antibiotics resistance and safe and effective practice of antibiotics use in the
region. For instance, the European Antibiotic Awareness Day is celebrated on 18 November every year. On
November 16, 2018, the symposium for the 11th European Antibiotic Awareness Day was hosted by the
Federal Ministry for Labour, Social Affairs, Health and Consumer Protection in cooperation with the
Austrian national reference centre. The agenda for the symposium focused on raising awareness about
importance of prudent antibiotic use.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2313
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Sulfadiazine Sodium Injection Market: Key Players
●
AdvaCare Pharma
●
Mercator Pharma
●
Shijiazhuang ZDHF Stock-Raising
●
Pegasus Laboratories
●
Weifang Fubang Pharmaceutical
●
Hebei Tianyuan Pharmaceutical
View this report @
https://www.coherentmarketinsights.com/ongoing-insight/sulfadiazine-sodium-injection-market-2313
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To k no w mor e abo ut us , v is it o ur w eb site:
w ww.coh er en tmark etins ig hts.com
THANK YOU
© Coherent market Insights. All Rights Reserved
F or s ales q ueries o r new top ics email u s o n :
s ales@coh er en tmark etins ig hts .co m
Fo r o th er q uer ies co n tact:
Mr. Sh ah
( Man ag er - Bus iness D ev elo pment)
Co herent Mark et Ins ig hts
s ales@coh er en tmark etins ig hts .co m
+1 -2 06 -7 0 1- 67 02

It is used in treating toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections. It is used for prevention of recurrent attacks of rheumatic fever, urinary tract infections, and chlamydial infections in humans.